Anxiety, depression, and insomnia

Primary Care - Clinics in Office Practice

Volumn 29, Issue 2, 2002, Pages 339-360

  Larzelere, Michele M ^a   Wiseman, Pamela ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; 5 METHYLTETRAHYDROFOLIC ACID; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; APIGENIN; CHAMOMILE; CYCLOSPORIN; DIGOXIN; FLAVONOID; FLUOXETINE; FOLIC ACID; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; KAVA; LAVENDER OIL; MELATONIN; ORAL CONTRACEPTIVE AGENT; PRASTERONE; S ADENOSYLMETHIONINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; VALERIAN; WARFARIN;

ACUPUNCTURE; ALLERGY; ALTERNATIVE MEDICINE; ANXIETY NEUROSIS; BEHAVIOR THERAPY; CLINICAL TRIAL; DEPRESSION; EXERCISE; HANGOVER; HEADACHE; HIRSUTISM; HUMAN; INSOMNIA; LEISURE; LEMON; MANIA; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SLEEP PATTERN; XEROSTOMIA; YOGA; ANXIETY; LIFESTYLE; MEDITATION; METHODOLOGY; PHYTOTHERAPY; UNITED STATES;

ACUPUNCTURE; ANXIETY; COMPLEMENTARY THERAPIES; DEPRESSION; EXERCISE; HUMAN; LIFE STYLE; MEDITATION; PHYTOTHERAPY; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES; HUMANS;

EID: 0036310314     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(01)00003-3     Document Type: Review

References (131)

1. The use of complementary and alternative therapies to treat anxiety and depression in the United States
2. Why patients use alternative medicine: Results of a national study
3. Unconventional medicine in the United States: Prevalence, costs, and patterns of use
4. Epidemiology of depression in primary care
5. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Survey
6. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study
7. Health care costs of primary care patients with recognized depression
8. The use of herbal alternative medicine in neuropsychiatry
9. St. John's wort: Prozac from the plant kingdom
10. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity
11. Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract
12. Hypericum perforatum (St. John's Wort): A non-selective reuptake inhibitor? A review of recent advances in its pharmacology
13. St John's wort for depression: An overview and meta-analysis of randomized clinical trials
14. St John's wort for depression
15. St. John's Wort for depression: A systematic review
16. Comparison of St John's wort and imipramine for treating depression: Randomized controlled trial
17. Effectiveness of St John's Wort in major depression: A randomized controlled trial
18. NIH to explore St. John's wort
19. Equivalence of St John's wort extract (Ze 117) and fluoxitine: A randomized, controlled study in mild-moderate depression
20. Potential treatment for subthreshold and mild depression: A comparison of St. John's wort extracts and fluoxetine
21. Adverse effects of herbal drugs in dermatology
22. Efficacy and tolerability of St. John's Wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10
23. Effect of antenatal exposure to Saint John's Wort (Hypericum) on neurobehavior of developing mice
24. Effect of prenatally administered hypericum (St John's wort) on growth and physical maturation of mouse offspring
25. Acute heart transplant rejection due to Saint John's wort
26. Indinavir concentrations and St John's wort
27. St John's wort interaction with Digoxin
28. Safety of St John's wort (Hypericum perforatum)
29. Mood-lowering effect of tryptophan depletion, enhanced susceptibility in young men at genetic risk for major affective disorder
30. The treatment of depression in general practice: A comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo
31. The cause of and pathogenesis of the eosinophilia-myalgia syndrome
32. Fluoxetine: Adverse effects and drug-drug interactions
33. 5-Hydroxytryptophan: A clinically-effective serotonin precursor
34. A functional-dimensional approach to depression: Serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine
35. SAMe (S-adenosylmethionine)
36. S-adenosylmethionine blood levels in major depression: Changes with drug treatment
37. Doubl-blind treatment of major depression with dehydroepiandosterone
38. Endogenous levels of dehydroepiandosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: The Rancho Bernardo study
39. Chronobiological study of some neuroendocrine features of major depression in elderly people
40. Neuropsychiatric function and dehydroepiandosterone sulfate in elderly women: A prospective study
41. Effects of replacement dose of dehydroepiandosterone in men and women of advancing age
42. Dehydroepiandosterone (DHEA) treatment of depression
43. Dehydroepiandosterone treatment of midlife dysthymia
44. DHEA: Dehydroepiandosterone
45. Serum and red blood cell folate in depression
46. Nutrition and depression: The role of folate
47. 12 deficiency and depression in physically disabled older women: Epidemiologic evidence from the women's health and aging study
48. Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: Results of a double-blind multicenter study
49. Folates: Supplemental forms and therapeutic application
50. The influence of physical activity on mental well-being
51. Physical activity and personal characteristics associated with depression and suicide in American college men
52. The effect of exercise on clinical depression and depression resulting from mental illness: A meta-analysis
53. Physical activity, fitness, and depression
54. The relationship between physical activity and clinically defined depression
55. Effect of exercise on depression
56. A randomized controlled trial of progressive resistance training in depressed elders
57. Exercise treatment for major depression: Maintenance of therapeutic benefit at 10 months
58. Effects of exercise training on older patients with major depression
59. Comparing aerobic with nonaerobic forms of exercise in the treatment of clinical depression: A randomized trial
60. Effects of aerobic exercise on depression: A controlled study
61. Clinical observation on needling extrachannel points in treating mental depression
62. Electro-acupuncture vs. amitriptyline in the treatment of depressive states
63. Clinical research on the therapeutic effect of the electro acupuncture treatment in patients with depression
64. The benefit from whole body acupuncture in major depression
65. Stress reduction through mindfulness meditation: Effects on psychological symptomatology, sense of control, and spiritual experience
66. Four-year follow-up of a meditation-based program for the self-regulation of chronic pain: Treatment outcomes and compliance
67. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders
68. Antidepressant efficacy of Sudarshan Kriya Yoga (SKY) in melancholia: A randomized comparison with electroconvulsive therapy (ECT) and imipramine
69. An experimental study of the effects of distant, intercessory prayer on self esteem, anxiety and depression
70. One-month prevalence of mental disorders in the United States
71. Gas-liquid chromatographic determination of major constituents of Piper methysticum
72. Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)
73. Kava-kava extract WS1490 versus placebo in anxiety disorders: A randomized placebo-controlled 25-week outpatient trial
74. Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis
75. Kava: Piper methysticum
76. Physical activity and psychological well-being: Knowledge base, current issues, and caveats
77. The effect of physical activity on physical and psychological health
78. Physical activity and mental health: Current concepts
79. A meta-analysis on the anxiety-reducing effects of acute and chronic exercise: Outcomes and mechanisms
80. Physical activity, anxiety, and stress
81. Differential effects of relaxation techniques on trait anxiety: A meta-analysis
82. Autogenic training for stress and anxiety: A systematic review
83. Psychosocial treatments for panic disorders, phobias, and generalized anxiety disorder
84. Psychological and behavioral treatments for post-traumatic stress disorder
85. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation
86. The clinical use of mindfulness meditation for the self-regulation of chronic pain
87. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders
88. Acupuncture in patients with minor depressive episodes and generalized anxiety: Results of an experimental study
89. Auricular acupuncture: A potential treatment for anxiety
90. Nonpharmacologic treatment of chronic insomnia: An American Academy of Sleep Medicine review
91. Economic effects of insomnia
92. A review of 12 commonly used medicinal herbs
93. Aqueous extract of valerian root reduces latency to fall asleep in man
94. Quantifying the effects of mild sedatives
95. Effect of valerian on human sleep
96. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality
97. Therapie von insomnien: Wirksamkeit und verträglichkeit eines bäldrian-praparates
98. Dietary supplements used in the treatment of depression, anxiety, and sleep disorders
99. The influence of valerian treatment on reaction time, alertness and concentration in volunteers
100. Melatonin, circadian rhythms, and sleep
101. A critical assessment of the melatonin effect on sleep in humans
102. Melatonin in medically ill patients with insomnia: A double-blind, placebo-controlled study
103. Improvement of sleep quality in elderly people by controlled-release melatonin
104. Nervous system disorders
105. A role for phytotherapy in the treatment of benzodiazepine and opiate drug withdrawal (part 1)
106. Behavioral effects of Passifora incarnata L. and its indole alkaloid and flavinoid derivative and maltol in the mouse
107. The effects of acute and chronic exercise on sleep: A meta-analytic review
108. Moderate-intensity exercise and self rated quality of sleep in older adults: A randomized controlled trial
109. Stimulus control instructions
110. Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy
111. Identifying effective psychological treatments for insomnia: A meta analysis
112. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia
113. Treatment of chronic insomnia by restriction of time in bed
114. Is sleep hygiene a sufficient treatment for sleep maintenance insomnia?
115. An evaluation of behavioral treatments for insomnia in the older adult
116. Nondrug treatment trials in psychophysiological insomnia
117. Effectiveness of combined triazolam-behavioral therapy for primary insomnia
118. Behavioral and pharmacological therapies for late life insomnia
119. Acupuncture and insomnia
120. The effectiveness of acupuncture in improving the quality of sleep of institutionalized residents